Sign in
8-K

Current Report

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-24-182544

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading d864314d8k.htm…